DR. REDDY'S LABORATORIES LIMITED

🇱🇰Sri Lanka
Ownership
-
Employees
-
Market Cap
-
Website
Clinical Trials
Related News

Cetirizine Hydrochloride Tablets, 10 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Cetirizine Hydrochloride
First Posted Date
2010-02-08
Last Posted Date
2010-02-08
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
30
Registration Number
NCT01064102

Risperidone Tablets, 1 mg Bioequivalence Study of Dr.Reddy's Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Risperidone
First Posted Date
2010-02-08
Last Posted Date
2010-02-08
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
30
Registration Number
NCT01064232

Carvedilol 25 mg Film-coated Tablets, Bioequivalence Study of Dr. Reddys Under Fed Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Carvedilol
First Posted Date
2010-02-08
Last Posted Date
2010-02-08
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
24
Registration Number
NCT01064180

Bioequivalence Study of Dr. Reddy's Divalproex Sodium Coated Particles in Capsules, 125 mg, Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Divalproex Sodium
First Posted Date
2010-01-26
Last Posted Date
2010-01-26
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
34
Registration Number
NCT01056627
Locations
🇮🇳

Bioserve Clinical Research Pvt. Ltd., Hyd, Andhra Pradesh, India

Bioequivalence Study of Dr. Reddy's Divalproex Sodium Capsules (Sprinkle), 125 mg Under Fasting Conditions

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Divalproex Sodium
First Posted Date
2010-01-26
Last Posted Date
2010-01-26
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
34
Registration Number
NCT01055938
Locations
🇮🇳

Bioserve Clinical Research Pvt. Ltd., Hyd, Andhra Pradesh, India

Bioequivalence Study of Dr.Reddys Laboratories Limited, Glimepiride 1 mg Tablets in Healthy Subjects Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Glimepiride tablets 1 mg
First Posted Date
2010-01-21
Last Posted Date
2010-01-21
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
44
Registration Number
NCT01053689
Locations
🇨🇦

Anapharm Inc, Sainte-Foy, Quebec, Canada

Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fed Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Ibuprofen and Diphenhydramine Citrate
First Posted Date
2010-01-21
Last Posted Date
2010-01-21
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
40
Registration Number
NCT01053338
Locations
🇮🇳

GVK Biosciences Pvt. Ltd, Amirpet, Hyderabad, India

Bioequivalence Study of Dr.Reddy's Ibuprofen and Diphenhydramine Citrate 200 mg/38 mg Caplets Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Ibuprofen and Diphenhydramine Citrate
First Posted Date
2010-01-21
Last Posted Date
2010-01-21
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
40
Registration Number
NCT01053208
Locations
🇮🇳

GVK Biosciences Pvt. Ltd, Amirpet, Hyderabad, India

Bioequivalence Study of Dr.Reddy's Laboratories Limited, Glimepiride Tablets 1 mg Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Glimepiride
First Posted Date
2010-01-21
Last Posted Date
2010-01-21
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
44
Registration Number
NCT01052909
Locations
🇨🇦

Anapharm Inc, Sainte-Foy, Quebec, Canada

Bioequivalence Study of Naproxen Sodium 550 mg Tablets Under Fasting Condition

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Naproxen sodium
First Posted Date
2010-01-20
Last Posted Date
2010-05-27
Lead Sponsor
Dr. Reddy's Laboratories Limited
Target Recruit Count
26
Registration Number
NCT01052129
Locations
🇮🇳

Wellquest Clinical Research, Mumbai, Maharashtra, India

© Copyright 2024. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy